Marksans Pharma Opens Special Window for Physical Share Transfer Re-lodgment
Marksans Pharma Ltd 路 Others (Uncategorized) 路 17 Sept 2026, 7:50 pm
Marksans Pharma Opens Special Window for Physical Share Transfer Re-lodgment Following SEBI guidelines, Marksans Pharma Ltd. announced the opening of a one-year special window from 5th Feb'26 to 4th Feb'27 for re-lodging physical share transfer deeds. This applies to shares transacted prior to 1st Apr'19 that were previously rejected or unaddressed due to documentation deficiencies. Approved transfers will be credited exclusively in demat mode and subject to a mandatory one-year lock-in period, barring any transfer, pledge, or lien. Disputed cases and shares transferred to IEPF remain excluded from this process.
Original exchange filing (PDF)
More announcements from Marksans Pharma Ltd
- Transcript of Investors/Analyst meet on Q2 FY27 Financial Results 路 13 Nov 2026
- Audio Recording of investor(s)/analyst(s) meet Conference Call on Q2 FY 27 Financial Results 路 05 Nov 2026
- Allotment of Equity Shares under Marksans Employees Stock Option Scheme 2024 路 04 Nov 2026
- Press Release for Financial Results Q2FY27 路 04 Nov 2026
- Investor Presentation Q2FY27 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2026 路 04 Nov 2026
- Marksans Pharma Limited has submitted to the Exchange, unaudited financial results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Please find attached outcome of the Board meeting held on 04 November 2026 路 04 Nov 2026
